Consequently, it was found that higher MALAT1 expression level frequently occurs in LHSCC at an advanced stage (P < 0.05), indicating an expectancy that MALAT1 may act as an oncogene in the development of LHSCC and may be a biomarker indicating tumor advance. Here, MALAT1 is linked to neoplasm.